Skip to main content

TWO SIGMA INVESTMENTS, LP

Position in EBS — Emergent BioSolutions Inc.

CIK 1179392 NEW YORK, NY

Position in EBS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,091,819
-$698,343 QoQ
Shares Held
488,284
-15.4% QoQ
Ownership
0.952%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 194 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Derivatives in EBS

reported options exposure · as of Sep 30, 2021
CallValue
$395,553
CallShares
7,900
PutValue
$255,357
PutShares
5,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $775,744,366 across 48 Drug Manufacturers - Specialty & Generic names. EBS ranks #21 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EBS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,091,819 488,284
2026-03-31 $4,790,162 577,128
2025-12-31 $3,195,060 258,500
2025-09-30 $2,304,939 261,331
2025-06-30 $2,256,408 353,669
2025-03-31 $1,928,448 396,800
2024-12-31 $8,095,082 846,766
2024-09-30 $6,205,653 743,192
2024-06-30 $3,045,402 446,540
2024-03-31 $2,564,332 1,013,570
2023-12-31 $2,492,640 1,038,600
2023-09-30 $3,522,318 1,035,976
2023-06-30 $5,159,148 701,925
2023-03-31 $4,831,727 466,383
2022-12-31 $2,573,304 217,892
2022-06-30 $518,554 16,706
2022-03-31 $13,451,954 327,617
2021-12-31 $10,561,471 242,960
2021-09-30 $255,357 5,100
2021-09-30 $395,553 7,900
2021-06-30 $26,585,244 422,055
2021-06-30 $692,890 11,000
2021-06-30 $377,940 6,000
2021-03-31 $250,857 2,700
2020-09-30 $28,728,839 278,030
2020-03-31 $474,799 8,206